Know Labs Bio-RFID™ Platform Technology Identifies Blood Alcohol Levels

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB:KNWN) – a provider of diagnostic solutions,
released today a video presentation of its Bio-RFID™ platform
technology’s successful identification of blood alcohol levels. In the
video presentation, CEO Phil Bosua not only discusses the Company’s use
of Bio-RFID to detect blood alcohol levels, but the broad implications
for its technology platform.

The transcript of Phil Bosua’s presentation in the video states in part:

“Over the last month we’ve been powering through a ton of experiments
and innovations and are really happy to report we’ve now got an AI based
algorithm that allows our technology to detect blood alcohol levels
non-invasively. So it’s official – Bio-RFID is now a platform
technology. Not only can we detect the holy grail of biotech – blood
glucose – but also – blood alcohol, and more to come in the future.”

“You’re witnessing a technology emerge that will change personal
medicine forever. And we have even bigger plans for this that we hope
will transform early warning medical diagnosis”

Link to video:

About Know Labs, Inc.

Know Labs, Inc. is a public company whose shares currently trade under
the stock symbol “KNWN.” The company’s technology directs structured
light or radio waves through a substance or material to capture a unique
molecular signature. The Company refers to these signatures as ChromaID™
and Bio-RFID™. ChromaID and Bio-RFID are used to identify, detect, or
diagnose substance markers or biomarkers that may be invisible to the
human eye. ChromaID and Bio-RFID scanner modules can be integrated into
a variety of wearable, mobile or bench-top form factors. This patented
and patent pending, award-winning technology makes it possible to
effectively conduct analyses that could only previously be performed by
invasive and/or large and expensive lab-based tests. For more
information on Know Labs, follow the company on Twitter @TheKnowLabs and
visit the company’s website at

Safe Harbor Statement

This video at the link above and this release contains statements that
constitute forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements appear in
a number of places in this release and include all statements that are
not statements of historical fact regarding the intent, belief or
current expectations of Know Labs, Inc., its directors or its officers
with respect to, among other things: (i) financing plans; (ii) trends
affecting its financial condition or results of operations; (iii) growth
strategy and operating strategy. The words may, would, will, expect,
estimate, can, believe, potential and similar expressions and variations
thereof are intended to identify forward-looking statements. Investors
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and uncertainties,
many of which are beyond Know Labs, Inc.’s ability to control, and
actual results may differ materially from those projected in the
forward-looking statements as a result of various factors.


Know Labs, Inc.
Jordyn Theisen

error: Content is protected !!